XBP1 and neoplasm: The IRE1α-XBP1 signaling axis has been demonstrated to reduce expression of MHC class I polypeptide-related sequence A (MICA), a ligand for natural killer group 2D (NKG2D) receptors on NK cells, thereby compromising tumor recognition in melanoma214.